Detalles de la búsqueda
1.
Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
Neurobiol Dis
; 179: 106050, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809847
2.
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.
J Biol Chem
; 292(23): 9745-9759, 2017 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28450393
3.
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework.
MAbs
; 15(1): 2232087, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408314
4.
Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF.
Brain Commun
; 5(6): fcad306, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025276
5.
SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell level.
MAbs
; 12(1): 1709333, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955651
6.
Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.
MAbs
; 11(8): 1464-1478, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31462177
Resultados
1 -
6
de 6
1
Próxima >
>>